Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Prasugrel> ?p ?o. }
Showing items 1 to 97 of
97
with 100 items per page.
- Prasugrel abstract "Prasugrel (marketing name Effient in the US and India, and Efient in the EU) is a platelet inhibitor developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). Prasugrel was approved for use in Europe in February 2009, and is currently available in the UK. On July 10, 2009, the US Food and Drug Administration approved the use of prasugrel for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI.".
- Prasugrel atcPrefix "B01".
- Prasugrel atcSuffix "AC22".
- Prasugrel casNumber "150322-43-3".
- Prasugrel drugbank "DB06209".
- Prasugrel fdaUniiCode "34K66TBT99".
- Prasugrel iupacName "(RS)-5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-".
- Prasugrel iupacName "tetrahydrothieno[3,2-c]pyridin-2-yl acetate".
- Prasugrel pubchem "6918456".
- Prasugrel thumbnail Prasugrel_Enantiomers_Structural_Formulae_V.1.svg?width=300.
- Prasugrel wikiPageExternalLink 678.
- Prasugrel wikiPageExternalLink webcast.asp.
- Prasugrel wikiPageExternalLink default.asp?ID=151.
- Prasugrel wikiPageID "1939142".
- Prasugrel wikiPageRevisionID "585519408".
- Prasugrel atcPrefix "B01".
- Prasugrel atcSuffix "AC22".
- Prasugrel bioavailability "≥79%".
- Prasugrel c "20".
- Prasugrel casNumber "150322".
- Prasugrel chembl "1201772".
- Prasugrel chemspiderid "5293653".
- Prasugrel drugbank "DB06209".
- Prasugrel eliminationHalfLife "25200.0".
- Prasugrel excretion "Urine ; feces".
- Prasugrel f "1".
- Prasugrel h "20".
- Prasugrel hasPhotoCollection Prasugrel.
- Prasugrel image "Prasugrel.png".
- Prasugrel inchi "1".
- Prasugrel inchikey "DTGLZDAWLRGWQN-UHFFFAOYAR".
- Prasugrel iupacName "-5".
- Prasugrel iupacName "tetrahydrothieno[3,2-c]pyridin-2-yl acetate".
- Prasugrel kegg "D05597".
- Prasugrel legalUk "POM".
- Prasugrel legalUs "Rx-only".
- Prasugrel licenceEu "Efient".
- Prasugrel licenceUs "Prasugrel".
- Prasugrel medlineplus "a609027".
- Prasugrel metabolism "Rapid intestinal and serum metabolism via esterase-mediated hydrolysis to a thiolactone , which is then converted, via CYP450-mediated oxidation, to an active metabolite".
- Prasugrel molecularWeight "373.442".
- Prasugrel n "1".
- Prasugrel o "3".
- Prasugrel pregnancyCategory "B".
- Prasugrel pregnancyUs "B".
- Prasugrel proteinBound "Active metabolite: ~98%".
- Prasugrel pubchem "6918456".
- Prasugrel routesOfAdministration "Oral".
- Prasugrel s "1".
- Prasugrel smiles "CCOc1cc2cCCNCCC4CC4".
- Prasugrel stdinchi "1".
- Prasugrel stdinchikey "DTGLZDAWLRGWQN-UHFFFAOYSA-N".
- Prasugrel tradename "Effient, Efient".
- Prasugrel unii "34".
- Prasugrel verifiedfields "changed".
- Prasugrel verifiedrevid "461743382".
- Prasugrel subject Category:ADP_receptor_inhibitors.
- Prasugrel subject Category:Acetate_esters.
- Prasugrel subject Category:Cyclopropanes.
- Prasugrel subject Category:Eli_Lilly_and_Company.
- Prasugrel subject Category:Ketones.
- Prasugrel subject Category:Organofluorides.
- Prasugrel subject Category:Thienopyridines.
- Prasugrel type Abstraction100002137.
- Prasugrel type AcetateEsters.
- Prasugrel type Chemical114806838.
- Prasugrel type Compound114818238.
- Prasugrel type Ester114850483.
- Prasugrel type Ketone114926294.
- Prasugrel type Ketones.
- Prasugrel type Material114580897.
- Prasugrel type Matter100020827.
- Prasugrel type OrganicCompound114727670.
- Prasugrel type Part113809207.
- Prasugrel type PhysicalEntity100001930.
- Prasugrel type Relation100031921.
- Prasugrel type Substance100019613.
- Prasugrel type Drug.
- Prasugrel type DrugProduct.
- Prasugrel type FunctionalSubstance.
- Prasugrel comment "Prasugrel (marketing name Effient in the US and India, and Efient in the EU) is a platelet inhibitor developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). Prasugrel was approved for use in Europe in February 2009, and is currently available in the UK.".
- Prasugrel label "Prasugrel".
- Prasugrel label "Prasugrel".
- Prasugrel label "Prasugrel".
- Prasugrel label "Prasugrel".
- Prasugrel label "Prasugrel".
- Prasugrel sameAs Prasugrel.
- Prasugrel sameAs Prasugrel.
- Prasugrel sameAs Prasugrel.
- Prasugrel sameAs Prasugrel.
- Prasugrel sameAs m.067kt7.
- Prasugrel sameAs Q416232.
- Prasugrel sameAs Q416232.
- Prasugrel sameAs Prasugrel.
- Prasugrel wasDerivedFrom Prasugrel?oldid=585519408.
- Prasugrel depiction Prasugrel_Enantiomers_Structural_Formulae_V.1.svg.
- Prasugrel isPrimaryTopicOf Prasugrel.
